Glycemic effects of vildagliptin and metformin combination therapy in Indian patients with type 2 diabetes: An observational study (印度2型糖尿病患者使用维格列汀与二甲双胍联合治疗对血糖的影响：一项观察性研究)
Author:
Affiliation:
1. Apollo Gleneagles Hospital; Kolkata India
2. The Park Clinic; Kolkata India
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. Ten year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med.,2008
2. Understanding the long-term benefits and dangers of intensive therapy of diabetes;Nathan;Arch Intern Med.,2012
3. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care.,2012
4. Global guidelines for type 2 diabetes: Recommendations for standard, comprehensive and minimal care;IDF Clinical Guidelines Task Force;Diabet Med.,2006
5. Dipeptidyl peptidase IV (DPP IV) inhibitors: A new emerging drug class for the treatment of type 2 diabetes;Green;Diab Vasc Dis Res.,2006
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-07
2. Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management;Bioinformation;2021-03-31
3. Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes;Postgraduate Medicine;2017-02-08
4. Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin;Journal of Drug Assessment;2016-01-01
5. Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey – GALATA study;Current Medical Research and Opinion;2015-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3